BBD-B.TO vs. CORT
BBD-B.TO (Bombardier Inc) and CORT (Corcept Therapeutics Incorporated) are both stocks. BBD-B.TO operates in Aerospace & Defense (Industrials), while CORT operates in Biotechnology (Healthcare). Over the past 10 years, BBD-B.TO returned 20.28%/yr vs 32.82%/yr for CORT. At a 0.13 correlation, their price movements are largely independent.
Performance
BBD-B.TO vs. CORT - Performance Comparison
Loading charts...
Different Trading Currencies
BBD-B.TO is traded in CAD, while CORT is traded in USD. To make them comparable, the CORT values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, BBD-B.TO achieves a 32.97% return, which is significantly lower than CORT's 143.33% return. Over the past 10 years, BBD-B.TO has underperformed CORT with an annualized return of 20.28%, while CORT has yielded a comparatively higher 32.82% annualized return.
BBD-B.TO
- 1D
- -0.80%
- 1M
- 16.29%
- YTD
- 32.97%
- 6M
- 38.16%
- 1Y
- 199.93%
- 3Y*
- 69.11%
- 5Y*
- 63.28%
- 10Y*
- 20.28%
CORT
- 1D
- -0.12%
- 1M
- 48.32%
- YTD
- 143.33%
- 6M
- -4.33%
- 1Y
- 19.22%
- 3Y*
- 54.99%
- 5Y*
- 34.82%
- 10Y*
- 32.82%
BBD-B.TO vs. CORT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBD-B.TO Bombardier Inc | 32.97% | 138.87% | 83.71% | 1.80% | 24.45% | 250.00% | -75.13% | -4.93% | -33.00% | 40.28% |
CORT Corcept Therapeutics Incorporated | 143.33% | -34.09% | 68.28% | 56.12% | 9.08% | -24.35% | 111.07% | -13.16% | -19.80% | 131.92% |
Correlation
The correlation between BBD-B.TO and CORT is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Jul 12, 2006 | 0.13 |
Fundamentals
BBD-B.TO:
CA$31.21B
CORT:
$8.66B
BBD-B.TO:
$9.32
CORT:
$0.41
BBD-B.TO:
23.84
CORT:
202.17
BBD-B.TO:
0.61
CORT:
100.71
BBD-B.TO:
2.32
CORT:
12.51
BBD-B.TO:
$9.60B
CORT:
$769.10M
BBD-B.TO:
$1.88B
CORT:
$755.64M
BBD-B.TO:
$1.70B
CORT:
$3.66M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBD-B.TO vs. CORT — Risk / Return Rank
BBD-B.TO
CORT
BBD-B.TO vs. CORT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bombardier Inc (BBD-B.TO) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BBD-B.TO | CORT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.67 | ||
| Sortino ratioReturn per unit of downside risk | +3.67 | ||
| Omega ratioGain probability vs. loss probability | 1.57 | 1.18 | +0.39 |
| Calmar ratioReturn relative to maximum drawdown | 11.39 | 0.30 | +11.09 |
| Martin ratioReturn relative to average drawdown | 31.20 | 0.54 | +30.66 |
Loading charts...
Drawdowns
BBD-B.TO vs. CORT - Drawdown Comparison
The maximum BBD-B.TO drawdown since its inception was -96.85%, roughly equal to the maximum CORT drawdown of -95.16%. Use the drawdown chart below to compare losses from any high point for BBD-B.TO and CORT.
Loading charts...
Drawdown Indicators
| BBD-B.TO | CORT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.85% | -95.16% | -1.69% |
Max Drawdown (1Y)Largest decline over 1 year | -17.67% | -65.20% | +47.53% |
Max Drawdown (3Y)Largest decline over 3 years | -39.54% | -73.18% | +33.64% |
Max Drawdown (5Y)Largest decline over 5 years | -66.64% | -73.18% | +6.54% |
Max Drawdown (10Y)Largest decline over 10 years | -94.84% | -73.18% | -21.66% |
Current DrawdownCurrent decline from peak | -4.76% | -29.05% | +24.29% |
Average DrawdownAverage peak-to-trough decline | -57.04% | -55.38% | -1.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.44% | 35.80% | -29.36% |
Volatility
BBD-B.TO vs. CORT - Volatility Comparison
The current volatility for Bombardier Inc (BBD-B.TO) is 11.91%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 14.05%. This indicates that BBD-B.TO experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBD-B.TO | CORT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.91% | 14.05% | -2.14% |
Volatility (6M)Calculated over the trailing 6-month period | 38.80% | 85.29% | -46.49% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.28% | 77.07% | -25.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 54.79% | 74.94% | -20.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.28% | 67.73% | -7.45% |
Dividends
BBD-B.TO vs. CORT - Dividend Comparison
Neither BBD-B.TO nor CORT has paid dividends to shareholders.
Financials
BBD-B.TO vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between Bombardier Inc and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BBD-B.TO vs. CORT - Profitability Comparison
BBD-B.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bombardier Inc reported a gross profit of 245.90M and revenue of 1.57B. Therefore, the gross margin over that period was 15.6%.
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a gross profit of 162.02M and revenue of 164.90M. Therefore, the gross margin over that period was 98.3%.
BBD-B.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bombardier Inc reported an operating income of 175.08M and revenue of 1.57B, resulting in an operating margin of 11.1%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported an operating income of -49.60M and revenue of 164.90M, resulting in an operating margin of -30.1%.
BBD-B.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bombardier Inc reported a net income of 52.13M and revenue of 1.57B, resulting in a net margin of 3.3%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a net income of -31.20M and revenue of 164.90M, resulting in a net margin of -18.9%.
Frequently Asked Questions
BBD-B.TO and CORT have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for BBD-B.TO and CORT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer